Our approved summary
The ad promoted prescription-only medicines to the public which is not allowed and presented the tablet as a minor issue, misleading about its use (CAP 12.12).
Upheld by the ASA. Ruling published by the ASA on .
The ad promoted prescription-only medicines to the public which is not allowed and presented the tablet as a minor issue, misleading about its use (CAP 12.12).
What to do next
More ASA rulings explained
- The ad suggested a medicine would definitely work and promoted prescription-only medicines to the public, which is not allowed under the rules (CAP 12.12).
- The ad promoted prescription-only weight-loss medicines to the public by directing consumers to a website featuring named prescription medicines, which is not allowed under advertising rules (CAP 12.12).
Official ruling
The official ruling is the definitive version. Mystery Slopper is not affiliated with the ASA.